Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

BUY
$61.42 - $86.29 $10,318 - $14,496
168 Added 5.42%
3,270 $230,000
Q2 2022

Jul 18, 2022

BUY
$55.54 - $72.65 $172,285 - $225,360
3,102 New
3,102 $205,000
Q1 2021

Apr 14, 2021

SELL
$13.77 - $21.66 $41,296 - $64,958
-2,999 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$10.75 - $14.91 $32,239 - $44,715
2,999 New
2,999 $40,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.